Trials / Unknown
UnknownNCT05181787
Biomarkers of Atrial Fibrillation Complicated With Stroke Based on Proteomics and Metabolomics
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Yue LI · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Thrombus shedding in patients with atrial fibrillation (AF) can lead to cerebral artery embolism. Stroke caused by AF is very dangerous, which not only threatens the life of patients, but also seriously affects the quality of life. This study aims to explore the biomarkers of stroke in patients with AF by integrating proteomics and metabolomics data, and establish the network relationship of stroke in patients with AF, so as to reveal the molecular mechanism of stroke in patients with AF.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Proteomics | Proteomic data were obtained by LC-MS/MS Analysis-DIA platform. |
| DIAGNOSTIC_TEST | Metabolomics | Metabolomic data were obtained by UPLC-QTOF/MS platform. |
Timeline
- Start date
- 2021-12-20
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
- First posted
- 2022-01-06
- Last updated
- 2022-01-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05181787. Inclusion in this directory is not an endorsement.